Active Ingredient: PERFLUTREN
Proprietary Name: DEFINITY RT
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 13.04MG/2ML (6.52MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021064
Product Number: 002
Approval Date: Nov 17, 2020
Applicant Holder Full Name: LANTHEUS MEDICAL IMAGING INC
Marketing Status:
Prescription
Patent and Exclusivity Information